Guangzheng Eye Hospital Group Co.,Ltd
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Guangzheng Eye Hospital Group Co., Ltd. [002524. SZ] was founded in 2001 and listed on the A-share market of the Shenzhen Stock Exchange in 2010. Guangzheng Ophthalmology Group, relying on its two major advantages of "capital and brand", is committed to becoming a globally influential ophthalmic medical commercial institution. Currently, the group owns Shanghai New Vision Ophthalmology Hospital Group (hereinafter referred to as New Vision Ophthalmology), which is an outstanding chain ophthalmic medical brand in the industry. It has also collaborated with the high-quality ophthalmic hospital group Beijing Meiermu Hospital Group (hereinafter referred to as Meiermu Ophthalmology) in the industry. Among them, New Vision Ophthalmology was established in 2004, headquartered in Shanghai, and has a total of more than ten fully insured ophthalmic hospitals in various regions. Its technical level and business scale are at the forefront of the industry. Meiermu Eye was founded in 1988, with Beijing as the core and radiating to the North China region. It has a total of more than ten brand ophthalmic hospitals and is a teaching base for the Medical Department of Peking University. In the rapid and leapfrog development, Guangzheng Ophthalmology has absorbed advanced medical management experience and operational models, condensed and cultivated a large number of authoritative expert teams with excellent medical skills and rigorous treatment, as well as medical management talents with pioneering and innovative spirit, to provide high-quality ophthalmic medical services for more eye disease patients. At the same time, with the continuous introduction of advanced ophthalmic technology and equipment, Guangzheng Ophthalmology Group has formed a development strategy of high-quality ophthalmic chain hospitals based on the Yangtze River Delta, Beijing Tianjin Hebei, Sichuan Chongqing, and Greater Bay Area, with a focus on first and second tier cities, rooted in China and focusing on the world, with strong financial strength and industrial integration ability. It is committed to becoming an influential medical group in the global ophthalmic medical field. |
| Headquarter | Urumqi |
| Establish Date | 12/10/2001 |
| Listed Code | 002524.SZ |
| Listed Date | 12/17/2010 |
| Chairman | Zhou Yonglin. |
| CEO | Zhou Yonglin. |
| Website |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
